Media ININ Economy We Trust
Ras Al-Khaimah, June 21 2020 WAM
Gulf Pharmaceutical Industries, “Julphar”, has resumed its activity in the Saudi Arabian market after a pause .. The company’s headquarters in Ras Al-Khaimah yesterday left a group of trucks loaded with pharmaceutical products bearing the words “Made in Julphar” and registered The Food and Drug Authority in the Kingdom of Saudi Arabia has one hundred products.
Sheikh Saqr bin Humaid Al Qasimi, Chairman of Julphar Board of Directors, said: “We are pleased to announce the return of 100 medicines from Julphar production and registered with the Food and Drug General Authority to the Saudi market.”
He added: “On our part, we confirm our confidence in our medicines, which constitute effective therapeutic solutions for many diseases, and our constant eagerness and commitment to cooperate with all concerned authorities in the pharmaceutical affairs inside and outside the country, especially the development of manufacturing processes and the implementation of all recommendations contained in inspection reports that the company’s factories witnessed during the last period. “.
Gulf Pharmaceutical Industries “Julphar” owns 12 factories in its headquarters in Ras Al Khaimah and another in Jebel Ali in addition to three factories outside the UAE in Saudi Arabia, Ethiopia and Bangladesh.
